Save the Date - Friday, March 27!
Register Now for the Spring NLARx Meeting, in Montpelier, Vermont.
Topics to include: expanding access to affordable prescription drugs through 340B; update on trade issues; the latest action in Congress on reimportation, Medicare Part D, sunshine law and more; gift bans and disclosure legislation in Vermont and other states. More>>
|
NLARx News
NLARx Testimony before the VT Senate Health & Welfare Committee More
Statement of Sharon Treat at PIJIP Forum on Innovation and Access to Medicines More
Media Release More
DC Council Member and NLARx Chair Catania Appointed to George Washington Faculty More
NLARx Report: Rx Action in the States, 2009 More |
In the States
WISCONSIN: Pfizer Ordered To Pay $9M for Defrauding Medicaid Program More
MONTANA: House Rejects Measure Preventing Sale of Drug-Prescription Info for Marketing More
Data Mining Bill Dies in Pure Party line Vote More
NEW HAMPSHIRE: Medical Identity Theft Bill Pending More
IMS Request for Emergency Stay Denied More
MARYLAND: Academic Detailing Bills Have Hearings More
ILLINOIS: Prescriber Privacy Bill Introduced More
COLORADO: Gift Ban Killed More
Discount Program Preserved More
NEW YORK: Savings from Generic Usage More
NORTH DAKOTA: Committee Opposes Pharmacy Law Repeal More
CONNECTICUT: Slew of Pharmaceutical Bills Filed More
TEXAS: PBM Bills Pending in Legislature More |
Outrage of the Week
Georgia Leads the Way in "Bad Bills" More
|
Fraud & Abuse
Dept of Justice Joins Lawsuits Over Alleged Illegal Marketing of Heart Medication Natrecor More
Pharma Lawyers Now Driving Billion Dollar Settlements More
Jury Rules Against Pfizer in Wisconsin Lawsuit More
|
Prices and Access to Healthcare
Health Care Spending Will Account for One-Fifth of GDP in 2018 More
54% of Unemployed People In Families With Incomes Below 200% of Poverty Level Are Uninsured More
GSK Announces Plan To Reduce Drug Prices in Developing Countries More
As More Lose Jobs and Coverage, More Turn to Free Drug Programs More |
Advertising and Marketing
Medtronic to Report Pay to Doctors Who Get $5,000 Annually More
Justice Dept Off-Label Marketing Lawsuits More
Study Researches Ways of Getting Drug Information to Consumers More
A Tithe on Pharmaceutical Marketing for Promoting Health More
Bayer to Run Corrective Ad for Birth-Control Pill More
Study on Medical Student Exposure to Pharma More
|
Conflicts of Interest
Consumer Groups: New FDA Chief Should Have Expertise, No Industry Ties More
BIO Encourages Its Members To Adopt Code Of Conduct for Interactions With Physicians More
Psychiatrists May Cut Some Ties To Drug Firms More
Harvard Medical School to Examine
Conflict-of-Interest Policies for Faculty More
|
Pharma Watch
Big Drug Makers May Seek to Fill Holes in Roster More
Smaller Drugs To Be Pulled From Market? More
PhRMA Statement on Economic Stimulus Law More
Pfizer Drops Two Late-Stage Drugs, Putting Resources Elsewhere More
Bridging the 'Talent Gap' in Generics More
|
PBM Watch
FTC, HHS Charge CVS Caremark Violated
Privacy Rights More
CVS Caremark's Privacy Practices Raised at Maryland Senate Hearing More
CVS Net Rises; Finance Chief Plans to Retire More
Medco Health's Profit Rises on Mail-Order, Generic Gains More
Challenge Grant for Mental Health Part of Settlement with PBMs More
Generic Drugs Are Boon to Middlemen More
|
Medicare
Feds Allege Wellcare 'Misled and Confused Medicare Beneficiaries' More
Community Pharmacists Campaign Against Reimbursement Rate Cuts More
Cancer Drug Medicare Guides Incomplete, Outdated, Study Finds More
Coordinated Care Programs Fail To Realize Medicare Savings, Patient Health Benefits, Study Finds More
|
Medicaid
Wisconsin Jury Finds Pharmacia Cheated
Medicaid Program, Should Pay $9 Million More
Utah Joint Resolution Would Eliminate Medicaid Qualified Asset Tests More
|
Patents and Generics
FTC Commissioner Thinks Obama Administration Will Help Stop Agreements To Delay Generics More
Merck Tries to Keep Singulair from Going Generic More
Sepracor's Lunesta Targeted by Generics More
|
Safety and Clinical Trials
Pfizer Drops Two Drugs from Late-Stage Pipeline More
FDA Says It Erred on Doctor More
Controlling Off-Label Medication Use More
U.S. Inoculates Vaccine Makers More
U.S. Court Finds No Link Between Vaccines, Autism More
Sanofi Heart Drug May Soon Be Approved for Use in US, Europe More
FDA Advises Public of Serious Adverse Event with Psoriasis Drug Raptiva More
Treating Heart Attacks With Prescription Drugs Alone as Effective as Using Stents More
Study: Popular Arthritis Drugs Could Increase the Risk of Shingles More
Menopause Drug Tied to Breast Cancer Recurrence More
FDA Proposes Strengthening Drug Safety More
Obama Signs Economic Stimulus Bill With Funding for Comparative Research More
FDA Approves ATryn, First Drug Made From Genetically Engineered Animals More |
Federal Developments
Privacy Provisions in the Electronic Records Section of the Stimulus Law More
NIH, NSF Win Big in Stimulus Plan More
Sen. Grassley's Efforts To Overhaul Pharmaceutical Industry, FDA More
|
